Disease ID | Disease name | Source of annotation with EXOSC8 | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
616081 | PONTOCEREBELLAR HYPOPLASIA, TYPE 1C | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | EXOSC8 |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
RNA degradation | hsa03018 | 6.48 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
PERK regulates gene expression | R-HSA-381042 | 8.18 |
Unfolded Protein Response (UPR) | R-HSA-381119 | 6.56 |
Gene Expression | R-HSA-74160 | 2.72 |
mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.52 |
Metabolism of proteins | R-HSA-392499 | 3.41 |
ATF4 activates genes | R-HSA-380994 | 8.34 |
Tristetraprolin (TTP) destabilizes mRNA | R-HSA-450513 | 8.89 |
Butyrate Response Factor 1 (BRF1) destabilizes mRNA | R-HSA-450385 | 8.89 |
KSRP destabilizes mRNA | R-HSA-450604 | 8.89 |
Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.56 |
Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.37 |
GO term | GO ID | GO IC |
---|---|---|
hydrolase activity | GO:0016787 | 1.9 |
nucleic acid binding | GO:0003676 | 1.44 |
nuclease activity | GO:0004518 | 4.33 |
organic cyclic compound binding | GO:0097159 | 1.05 |
exonuclease activity | GO:0004527 | 5.33 |
ribonuclease activity | GO:0004540 | 5.04 |
exoribonuclease activity | GO:0004532 | 6.21 |
hydrolase activity, acting on ester bonds | GO:0016788 | 3.1 |
AU-rich element binding | GO:0017091 | 6.6 |
catalytic activity | GO:0003824 | 1.05 |
binding | GO:0005488 | 0.18 |
protein binding | GO:0005515 | 0.46 |
heterocyclic compound binding | GO:1901363 | 1.06 |
RNA binding | GO:0003723 | 2.36 |